EMROSI 40 mg/1
Minocycline Hydrochloride Extended-Release · CAPSULE · Journey Medical Corporation
EMROSI is a capsule containing minocycline hydrochloride extended-release at 40 mg/1, taken oral. Manufactured by Journey Medical Corporation.
Key Facts
- Brand Name
- EMROSI
- Generic Name
- Minocycline Hydrochloride Extended-Release
- NDC Code (Product)
69489-131- Manufacturer
- Journey Medical Corporation
- Strength
- 40 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA219015
- Marketing Start
- 03/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is EMROSI used for?
EMROSI contains Minocycline Hydrochloride Extended-Release. It is a capsule taken oral. Consult your doctor for specific uses.
Is EMROSI a controlled substance?
EMROSI is not classified as a controlled substance by the DEA.
What is the generic name for EMROSI?
The generic name for EMROSI is Minocycline Hydrochloride Extended-Release. There are no other listed brand versions of Minocycline Hydrochloride Extended-Release.
What is the NDC code for EMROSI 40 mg/1?
The NDC (National Drug Code) for EMROSI 40 mg/1 is 69489-131, listed by Journey Medical Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)